.png)
Age and Egg Quality: Understanding the Science Behind Maternal Age and Chromosomal Health
If you are in your late thirties or forties and thinking about IVF, the phrase "egg quality" may feel like something you hear constantly but understand only vaguely. Clinicians mention it. Articles reference it. But what does it actually mean, biologically — and what does it mean for you specifically?
The relationship between age and egg quality is real. But it is not a cliff that every woman falls off at the same point. It is a gradual shift that looks different for every person, depending on their ovarian reserve, health history, and biology. Understanding the science helps you ask better questions — and make more informed decisions about your next steps.
At Hanabusa IVF, the approach to egg quality and maternal age starts with your individual biology. The team does not apply a single framework to every patient in their late thirties or forties. Every evaluation is personalized, and every protocol is built around what your ovaries are actually doing.
The Biology of Aging Eggs
Women are born with all the eggs they will ever have. These eggs remain in a suspended state of development until they are recruited for ovulation each month. Over time, the biological machinery within each egg — including the spindles and chromosomes responsible for proper cell division — becomes more susceptible to errors.
When an egg matures and is fertilized, it must undergo a precise series of chromosomal divisions. In younger eggs, this process is highly accurate. In older eggs, the probability of errors increases. These errors result in embryos that are chromosomally abnormal (aneuploid) — and aneuploid embryos are the leading cause of failed implantation and early pregnancy loss.
This is not a flaw specific to any individual. It is a biological reality that affects all eggs to varying degrees as women age — and it is the primary reason fertility outcomes shift across different age groups in IVF.
What Changes and When
Egg quality does not decline on a schedule. Research consistently shows that the proportion of chromosomally normal eggs decreases progressively from the mid-thirties onward, with a more noticeable acceleration in the early-to-mid forties. But there is significant individual variation.
Some women in their early forties produce eggs with chromosomal profiles that resemble those of a woman in her mid-thirties. Others experience earlier decline. Ovarian reserve testing — including AMH levels, FSH, and antral follicle count — provides a partial picture of reserve but does not directly predict chromosomal quality. Only embryo testing through PGT-A can reveal what proportion of a given patient's eggs produce euploid (chromosomally normal) embryos.
This variability is why Hanabusa IVF resists blanket statements about what any given patient's egg quality looks like based on age alone. A proper individual evaluation is the only way to build a protocol that actually reflects your biology.
How Stimulation Affects Chromosomal Outcomes
One factor that is often underappreciated in discussions of egg quality is the role of stimulation. High-dose stimulation recruits a large cohort of follicles, but not all of those follicles are at the same stage of readiness. Forcing immature follicles to overstimulation can increase the proportion of eggs with chromosomal errors — the very problem older patients are already managing.
At Hanabusa IVF, the stimulation philosophy reflects this understanding. The clinic does not pursue maximum follicle counts as the primary goal. Instead, the protocol is designed to support the maturation of the follicles most likely to produce high-quality eggs — even if that means retrieving fewer eggs overall.
"More eggs is not always the answer. For patients where egg quality is a concern, we focus on the conditions under which each egg matures. A well-matched, individualized protocol often produces a smaller number of chromosomally healthier eggs than a high-dose approach that pushes the ovaries beyond their natural rhythm."
— Dr. Lyndon Chang, Medical Director at Hanabusa IVF
Connecting Egg Quality to Embryo Development
The clearest window into egg quality during an IVF cycle is embryo development. Eggs that were chromosomally compromised at retrieval often show it during fertilization and culture. They may fertilize abnormally, arrest before reaching the blastocyst stage, or develop more slowly than expected.
When embryo development is poor across a cycle — especially in a patient with reasonable ovarian reserve — the protocol itself is worth examining. Was stimulation appropriate for this patient's biology? Were the eggs given the right hormonal environment to mature? These are questions Hanabusa IVF asks systematically when reviewing cycle outcomes, particularly for patients who have experienced prior failures elsewhere.
Preimplantation Genetic Testing as a Diagnostic Tool
For patients concerned about chromosomal health, PGT-A testing of embryos is one of the most direct ways to understand what is happening with egg quality in practice. By genetically screening embryos before transfer, PGT-A identifies which embryos are chromosomally normal and provides a concrete picture of what a given retrieval actually produced.
This data has diagnostic value beyond the current cycle. A pattern of few or no euploid embryos can inform decisions about stimulation approach, cycle timing, and future treatment pathways. At Hanabusa IVF, the team uses this information constructively — not to discourage patients, but to give them the clearest possible foundation for the decisions ahead.
"What I want patients to take away from genetic testing results is not a verdict, but information. When we know what a cycle actually produced, we can have a much more honest and productive conversation about what to do next."
— Dr. Diana LeBlanc, a Fertility Specialist at Hanabusa IVF
When Egg Quality Concerns Lead to a Conversation About Donor Eggs
For some patients — particularly those in their mid-to-late forties or those with very low ovarian reserve — own-egg IVF may produce few or no chromosomally normal embryos across multiple cycles. In those cases, the most clinically honest path involves a frank conversation about donor eggs.
Hanabusa IVF's donor egg program is designed for patients who have reached this crossroads thoughtfully. The team does not push patients toward donor eggs before own-egg options have been genuinely explored. But they also do not withhold an honest assessment when the data points clearly in one direction.
Frequently Asked Questions
Does egg quality decrease with age for everyone?
Yes, chromosomal quality of eggs declines progressively with age for all women, but the rate and extent of decline vary considerably between individuals. Testing — particularly PGT-A of embryos — provides the clearest picture of where any given patient stands.
At what age does egg quality start to decline?
Research shows that chromosomal abnormalities in eggs increase gradually from the mid-thirties, with a more pronounced acceleration in the early-to-mid forties. However, individual variation is significant — some women in their early forties have good chromosomal outcomes, while others may experience earlier decline.
Can I improve my egg quality with supplements or lifestyle changes?
While some lifestyle factors may support overall reproductive health, the chromosomal changes associated with aging are not reversible through supplements or lifestyle interventions. The most evidence-supported approach to optimizing outcomes is a well-designed, individualized stimulation protocol.
How does PGT-A testing help with egg quality concerns?
PGT-A tests embryos for chromosomal abnormalities before transfer. It reveals what proportion of retrieved eggs produced chromosomally normal embryos, which gives a direct picture of egg quality outcomes from a given cycle and helps inform decisions about future treatment.
Is it possible to have good egg quality at 40 or older?
Yes. While average chromosomal quality declines with age, individual outcomes vary widely. Some patients at 40 or older produce a meaningful proportion of chromosomally normal embryos, particularly when stimulation protocols are well-matched to their biology.
Individualized Assessment Is the Starting Point
Age and egg quality are connected — but they are not synonymous. Your age gives a probabilistic picture. Your individual biology gives the actual one. At Hanabusa IVF, the evaluation of fertility after 40 starts with exactly that individual biology — your hormone levels, your follicle count, your prior cycle history if you have one, and your goals.
Whether you are considering IVF for the first time or rethinking a previous plan, the team at Hanabusa IVF is here to help you understand what is actually true for your situation — and to build a protocol that works with your biology rather than against it.
